Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-024510
Filing Date
2019-05-08
Accepted
2019-05-08 16:16:12
Documents
45
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv520436_10q.htm 10-Q 223065
2 EXHIBIT 31.1 tv520436_ex31-1.htm EX-31.1 11315
3 EXHIBIT 31.2 tv520436_ex31-2.htm EX-31.2 11729
4 EXHIBIT 32.1 tv520436_ex32-1.htm EX-32.1 5052
5 EXHIBIT 32.2 tv520436_ex32-2.htm EX-32.2 5499
  Complete submission text file 0001144204-19-024510.txt   1518855

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20190331.xml EX-101.INS 231546
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20190331.xsd EX-101.SCH 22205
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20190331_cal.xml EX-101.CAL 13157
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20190331_def.xml EX-101.DEF 92357
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20190331_lab.xml EX-101.LAB 128647
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20190331_pre.xml EX-101.PRE 121187
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 19806799
SIC: 2836 Biological Products, (No Diagnostic Substances)